Saxenda for weight loss: separating real results from TikTok hype

What did @dr.pablomonert actually say?

Honestly? Very little about Saxenda. The transcript of this 1.9-million-view video is a jumbled, largely incoherent string of phrases about schools, money, water, and country-building. There is no discernible medical claim, dosing information, or clinical explanation of how liraglutide works. The video is captioned about Saxenda for weight loss, but the spoken content does not match that topic in any meaningful way.

This creates an immediate problem for fact-checking. The caption promises information about a regulated GLP-1 receptor agonist used in obesity treatment. The actual audio delivers something closer to a disconnected speech fragment. Viewers drawn in by the hashtags "saxenda" and "obesidad" are not getting what the packaging implies. That gap between caption and content is itself a credibility issue, regardless of the creator's intent.

Does the science back this up?

Since no specific medical claims were made in the transcript, there is nothing to verify against the literature. However, the topic the video was supposed to address, Saxenda and weight loss, is an area with a solid evidence base worth reviewing.

Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist approved by the FDA for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition. The SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine) found that participants on liraglutide lost an average of 8.4 kg more than those on placebo over 56 weeks. That is meaningful but not transformative compared to newer agents. Tirzepatide, for context, showed average weight reductions above 20% in the SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM). Liraglutide works, but it is no longer the most effective option in its class.

What did they get wrong (or right)?

There is nothing to label right or wrong in the clinical sense because no clinical content was delivered. What the creator got wrong is the basic responsibility of producing coherent health content under a medical professional's brand. A video captioned with a prescription medication name, posted by an account presenting as a physician, carries an implicit promise of accuracy and usefulness.

The hashtag "drpablomonert" and the medical facility tag "torremedicasanandres" suggest this is positioned as professional medical commentary. When a video wearing that label delivers no actual information about the drug in question, it is not neutral. It can drive viewers to search for Saxenda information elsewhere, potentially landing on far worse sources. The absence of misinformation is not the same as the presence of responsible communication.

What should you actually know?

If you found this video searching for information about Saxenda, here is what the video did not tell you.

• Saxenda requires a prescription and should only be used under supervision of a licensed clinician who has reviewed your full medical history.
• Common side effects include nausea, vomiting, diarrhea, and constipation, particularly in the first weeks of use. These are dose-dependent (Davies et al., 2015, The Lancet).
• Saxenda is not appropriate for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
• Weight loss results vary substantially. The SCALE trial showed about 63% of participants achieved at least 5% weight loss, meaning roughly 37% did not hit that threshold.
• Stopping Saxenda is associated with weight regain. It is a chronic treatment, not a short-term fix, and decisions about duration should be made with a clinician.

Anyone making treatment decisions based on a TikTok caption is working with incomplete information. That applies here more than most.